Edap Tms (EDAP) Liabilities and Shareholders Equity (2009 - 2026)
Edap Tms (EDAP) reported Liabilities and Shareholders Equity of $72.1 million for Q1 2026, down 8.63% on a YoY basis from $78.9 million in Q1 2025, and down 8.78% quarter-over-quarter from $79.0 million in Q4 2025.
Edap Tms (EDAP) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Edap Tms has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $72.1 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 8.63% year-over-year to $72.1 million; the trailing twelve-month figure through Mar 2026 stood at $300.3 million (down 13.25% YoY), and the FY2025 full-year result was $79.0 million, down 14.1% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $72.1 million, down from $79.0 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $108.2 million in Q1 2023, with the low at $71.9 million in Q3 2025.
- Historically, Liabilities and Shareholders Equity has averaged $90.3 million across 5 years, with a median of $88.5 million in 2024.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 31.9% — and 2025, when it declined 18.5%.
- Edap Tms' Liabilities and Shareholders Equity stood at $103.2 million in 2022, then retreated by 4.53% to $98.5 million in 2023, then retreated by 6.63% to $92.0 million in 2024, then declined by 14.1% to $79.0 million in 2025, then declined by 8.78% to $72.1 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $72.1 million (Q1 2026), $79.0 million (Q4 2025), and $71.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 212.04 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 82.32 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 81.65 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 56.69 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 11.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.42 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 72.06 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 310.22 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 62.37 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.06 Mn |
| Dec 31, 2025 | 79.00 Mn |
| Sep 30, 2025 | 71.85 Mn |
| Jun 30, 2025 | 77.36 Mn |
| Mar 31, 2025 | 78.87 Mn |
| Dec 31, 2024 | 91.97 Mn |
| Sep 30, 2024 | 86.81 Mn |
| Jun 30, 2024 | 88.48 Mn |
| Mar 31, 2024 | 96.77 Mn |
| Dec 31, 2023 | 98.50 Mn |
| Sep 30, 2023 | 101.53 Mn |
| Jun 30, 2023 | 103.80 Mn |
| Mar 31, 2023 | 108.16 Mn |
| Dec 31, 2022 | 103.17 Mn |
| Sep 30, 2022 | 105.67 Mn |
| Jun 30, 2022 | 86.75 Mn |
| Mar 31, 2022 | 84.80 Mn |
| Dec 31, 2021 | 88.34 Mn |
| Sep 30, 2021 | 86.90 Mn |
| Jun 30, 2021 | 89.87 Mn |